FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,457 | -44.3% | 117,099 | 0.0% | 0.02% | -47.2% |
| Q2 2023 | $546,852 | +23.9% | 117,099 | 0.0% | 0.04% | +28.6% |
| Q1 2023 | $441,463 | +19.7% | 117,099 | 0.0% | 0.03% | +27.3% |
| Q4 2022 | $368,862 | +4.8% | 117,099 | 0.0% | 0.02% | +10.0% |
| Q3 2022 | $352,000 | +81.4% | 117,099 | +50.0% | 0.02% | +25.0% |
| Q2 2022 | $194,000 | -68.0% | 78,066 | 0.0% | 0.02% | -65.2% |
| Q1 2022 | $607,000 | +86.2% | 78,066 | 0.0% | 0.05% | +142.1% |
| Q4 2021 | $326,000 | -47.2% | 78,066 | 0.0% | 0.02% | -48.6% |
| Q3 2021 | $618,000 | – | 78,066 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |